Endangered marine mammals — seals, dolphins, whales, and otters — are almost as vulnerable as humans in becoming infected from
Read more
Home » respiratory »
respiratory
flagyl kansas
The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led
Read more
Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19
A recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from
Read more
Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients
Vaccines are very important in controlling the coronavirus disease 2019 (COVID-19) pandemic. Two highly effective mRNA vaccines are available in
Read more
Delaying second dose of Pfizer-BioNTech SARS-CoV-2 vaccine may be feasible in some cases
Researchers in Spain have conducted the most extensive study to date investigating the effectiveness of vaccinating healthcare workers with a
Read more
Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies
Extensive testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a primary mitigation measure in controlling
Read more
lasix kidney pain
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19)
Read more
Researcher find an emergent SARS-CoV-2 variant in California
Researchers have found a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in California, USA. This variant is more
Read more
Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations
Viruses evolve under increased pressure, and new research from The Rockefeller University and University of Massachusetts Medical School in the
Read more
Optimized SARS-CoV-2 vaccine candidate could be less reactogenic, say researchers
A new study, released as a preprint on the bioRxiv* server, reports an optimized coronavirus disease 2019 (COVID-19) vaccine candidate,
Read more